HEAD AND NECK CANCER DRUGS MARKET ANALYSIS

Head and Neck Cancer Drugs Market, By Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy), By Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Jun 2023
Code : CMI530
Pages :130
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Merck & Co., Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Astrazeneca Plc., Fresenius Medical Care AG & CO. KGAA, and F. Hoffmann-la Roche Ltd. (Genentech, Inc.), among others.

Global Head and Neck Cancer Drugs Market: Key Companies Insights

The global head and neck cancer drugs market is highly competitive. This is attributed to the rise in burden of head and neck cancer, as a result, players in the market are focusing on developing and launching novel drugs in the market.

Some of the key players in the global head and neck cancer drugs market are Merck & Co., Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Astrazeneca Plc., Fresenius Medical Care AG & CO. KGAA, and F. Hoffmann-la Roche Ltd. (Genentech, Inc.), among others.